Fig. 2From: Sintilimab for the treatment of non-small cell lung cancerAnti-tumor effects (A, B) and incidence of adverse effects (C) from clinical trials of sintilimab on non-small cell lung cancer patients. Dashed lines indicate absence of available corresponding dataBack to article page